Drug intelligence / Profile preview

KOHLE Dr. Mann

Development stage: Unknown
Lead developer: Dr. Gerhard Mann
Modality: Small Molecules
Administration: Oral

Overview

KOHLE Dr. Mann is an over-the-counter (OTC) medicinal charcoal product developed by Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, a subsidiary of Bausch + Lomb. Each tablet contains 250 mg of activated charcoal, which acts as a non-specific adsorbent within the gastrointestinal tract. The drug works through physical adsorption, binding to various toxins, chemicals, heavy metals, and microorganisms to prevent their absorption into the systemic circulation. It is primarily indicated for the treatment of acute diarrhea and gastrointestinal intoxication or poisoning resulting from food, medications, or heavy metal ingestion. The formulation is approved for use in Germany and is administered orally.

Brand names: KOHLE Dr. Mann
Other names: Activated charcoal (Dr. Mann)Medicinal charcoal

Beyond the preview

Go deeper on KOHLE Dr. Mann.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KOHLE Dr. Mann.

Explore the full profile